<p>Topoisomerase I and II DNA cleavage was induced by treatment of HTori-3 cells with 10 µM CPT-11 or VP-16, respectively, for 1.5 hours. The location of CPT 11- (n=22) or VP-16- (n=21) induced DNA cleavage within <i>RET</i> intron 11 was detected using LM-PCR and <i>RET</i> primer set 1 and compared to either topoisomerase I (CPT 11) or II (VP-16) predicted cleavage sites. A positive distance indicates the predicted cleavage site is downstream of the drug-induced site, and a negative distance indicates the predicted cleavage site is upstream. The percentage of all drug-induced breakpoints is represented on the y axis.</p
We analyzed the der(11) and der(4) genomic breakpoint junctions of a t(4;11) in the leukemia of a pa...
Fragile site breakage was previously shown to result in rearrangement of the RET oncogene, resemblin...
The poisoning of Topoisomerase II (Top2) has been found to be useful as a therapeutic strategy for t...
<p>(A) Topoisomerase I cleavage sites within <i>RET</i> intron 11 were predicted based on the consen...
Human topoisomerase I plays an important role in removing positive DNA supercoils that accumulate ah...
Human topoisomerase 11 (topo 11) is an essential enzyme that controls DNA topology by relieving posi...
Antitumor drugs, such as anthracyclines, interfere with mammalian DNA topoisomerase II by forming a ...
K6-1 and 50B-3 cell lines, resistant to VP-16, a DNA topoisomerase II inhibitor, were established fr...
<p><b>Copyright information:</b></p><p>Taken from "Molecular basis of the targeting of topoisomerase...
<p>DNA breaks formed in intron 11 of <i>RET</i> were detected by LM-PCR without treatment (A) or fol...
Camptothecin is an antitumor drug, which is a specific inhibitor of eukaryotic topoisomerase I. Enzy...
Alternating purine-pyrimidine sequences (RY repeats) demonstrate considerable homology to the consen...
The two known antineoplastic quinoxaline topoisomerase II poisons, XK469 (NSC 697887) and CQS (chlor...
Background: Chromosomal translocations leading to chimeric oncoproteins are important in leukemogene...
Although the application of the concept of a threshold to risk assessment is widespread, there remai...
We analyzed the der(11) and der(4) genomic breakpoint junctions of a t(4;11) in the leukemia of a pa...
Fragile site breakage was previously shown to result in rearrangement of the RET oncogene, resemblin...
The poisoning of Topoisomerase II (Top2) has been found to be useful as a therapeutic strategy for t...
<p>(A) Topoisomerase I cleavage sites within <i>RET</i> intron 11 were predicted based on the consen...
Human topoisomerase I plays an important role in removing positive DNA supercoils that accumulate ah...
Human topoisomerase 11 (topo 11) is an essential enzyme that controls DNA topology by relieving posi...
Antitumor drugs, such as anthracyclines, interfere with mammalian DNA topoisomerase II by forming a ...
K6-1 and 50B-3 cell lines, resistant to VP-16, a DNA topoisomerase II inhibitor, were established fr...
<p><b>Copyright information:</b></p><p>Taken from "Molecular basis of the targeting of topoisomerase...
<p>DNA breaks formed in intron 11 of <i>RET</i> were detected by LM-PCR without treatment (A) or fol...
Camptothecin is an antitumor drug, which is a specific inhibitor of eukaryotic topoisomerase I. Enzy...
Alternating purine-pyrimidine sequences (RY repeats) demonstrate considerable homology to the consen...
The two known antineoplastic quinoxaline topoisomerase II poisons, XK469 (NSC 697887) and CQS (chlor...
Background: Chromosomal translocations leading to chimeric oncoproteins are important in leukemogene...
Although the application of the concept of a threshold to risk assessment is widespread, there remai...
We analyzed the der(11) and der(4) genomic breakpoint junctions of a t(4;11) in the leukemia of a pa...
Fragile site breakage was previously shown to result in rearrangement of the RET oncogene, resemblin...
The poisoning of Topoisomerase II (Top2) has been found to be useful as a therapeutic strategy for t...